Kangstem Biotech, 29.93% ↑ Amid Rising Umbilical Cord Blood Theme

On the 7th, the umbilical cord blood theme rose by 3.10% compared to the previous day, showing strength, while Kangstem Biotech, a related stock attracting attention, surged by 29.93% compared to the previous day. Kangstem Biotech is known as a developer, manufacturer, and supplier of stem cell therapeutics.

[Graph] Major stock price changes in the umbilical cord blood theme

According to the analysis by Thinkpool Robo Algorithm RASSI, Kangstem Biotech's quant financial score was 12.32 points, ranking 6th in the quant financial ranking within the umbilical cord blood theme. This can be interpreted as Kangstem Biotech having relatively low investment attractiveness from a financial perspective. On the other hand, Cha Biotech ranked 1st in the quant financial ranking with higher growth and stability scores compared to the average of other stocks.

[Table] Top stocks by financial score within the theme

※ The quant financial score is the result of the Robo Algorithm's analysis based on each company's sales growth rate, equity growth rate, debt ratio, current ratio, ROA, ROE, etc.

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.